Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
This study has been completed.
Study NCT00031317   Information provided by National Institutes of Health Clinical Center (CC)
First Received: February 28, 2002   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Panic Disorder
Additional conditions recognized in this trial
Depression
Depressive Disorder
Disease
More general conditions related to this trial
Anxiety Disorders
Behavioral Symptoms
Mental Disorders
Mood Disorders
Pathologic Processes
Interventions listed in this trial
Paroxetine
Clozapine
Additional drug interventions recognized in this trial
Clonazepam
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Antagonists
GABA Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services